1.State-Mandated In Vitro Fertilization Coverage and Decrease in Multiple Gestation Rates: Helpful, But Not Enough.

2.Regionalization of Care for Peripartum Hysterectomy: The Time Has Come.

3.State Insurance Mandates and Multiple Birth Rates After In Vitro Fertilization.

4.Risk of Peripartum Hysterectomy and Center Hysterectomy and Delivery Volume.

5.Great Moments in Global Health, and Why We Are in One Now.

6.Maternal Deaths From Suicide and Overdose in Colorado, 2004-2012.

7.Prevalence of Human Papillomavirus in Self-Collected Cervicovaginal Swabs in Young Women in the United States Between 2003 and 2012.

8.Similar Risk Patterns After Cervical Screening in Two Large U.S. Populations: Implications for Clinical Guidelines.

9.Regeneration Process After Cervical Conization for Cervical Intraepithelial Neoplasia.

10.Adverse Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia.

11.Blood Loss as a Function of Body Surface Area: Redefining Parameters of Obstetric Blood Loss.

12.Prevalence, Indications, Risk Indicators, and Outcomes of Emergency Peripartum Hysterectomy Worldwide: A Systematic Review and Meta-analysis.

13.Risk Factors and Outcomes for Conversion to Laparotomy of Laparoscopic Hysterectomy in Benign Gynecology.

14.Naproxen Sodium for Pain Control With Intrauterine Device Insertion: A Randomized Controlled Trial.

15.Obesity and Tobacco Cessation Toolkits: Practical Tips and Tools to Save Lives.

16.Managing Recurring Obstetric Cholestasis With Metformin.

17.Relationship Between Excessive Gestational Weight Gain and Neonatal Adiposity in Women With Mild Gestational Diabetes Mellitus.

18.Social Contributors to Glycemic Control in Gestational Diabetes Mellitus.

19.Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of Pregnancy.

20.Treatment Decisions at the Time of Miscarriage Diagnosis.

21.Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial.

22.Enterovaginal or Vesicovaginal Fistula Control Using a Silicone Cup.

23.Readmission and Prolapse Recurrence After Abdominal and Vaginal Apical Suspensions in Older Women.

24.Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.

25.Hip Dislocation and Dystocia in Early Medieval Times: Possible Evidence of Labor Maneuver.

26.Oregon's Hard-Stop Policy Limiting Elective Early-Term Deliveries: Association With Obstetric Procedure Use and Health Outcomes.

27.Operationalizing 17[alpha]-Hydroxyprogesterone Caproate to Prevent Recurrent Preterm Birth: Definitions, Barriers, and Next Steps.

28.Palliative Care in Obstetrics and Gynecology.

29.Raspberry Leaf and Hypoglycemia in Gestational Diabetes Mellitus.

30.Imaging for Polyps and Leiomyomas in Women With Abnormal Uterine Bleeding: A Systematic Review.

31.Microangiopathic Hemolytic Anemia Due to Malignancy in Pregnancy.

32.What Is New in Medical-Legal Issues in Obstetrics and Gynecology?: Best Articles From the Past 2 Years.

33.Connect the Dots-December 2016.

34.Reduction in the Cesarean Delivery Rate After Obstetric Care Consensus Guideline Implementation.

35.In Reply.

36.All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy.

37.In Reply.

38.Insect Repellants During Pregnancy in the Era of the Zika Virus.

39.In Reply.

40.Obstetric Forceps: A Species on the Brink of Extinction andForceps, Simulation, and Social Media andSimulation Training for Forceps-Assisted Vaginal Delivery and Rates of Maternal Perineal Trauma.

41.In Reply.

42.In Reply.

43.National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism: Correction.

44.Self-Administered Lidocaine Gel for Pain Control With First-Trimester Surgical Abortion: A Randomized Controlled Trial: Correction.

45.Practice Bulletin No. 156: Obesity in Pregnancy: Correction.

46.Checklist.

47.Author Agreement.

48.Table of Contents: December 2016 Issue.

49.College Publications.

50.Practice Bulletin No. 175 Summary: Ultrasound in Pregnancy.

51.Committee Opinion No. 681 Summary: Disclosure and Discussion of Adverse Events.

52.Committee Opinion No. 682 Summary: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology.

53.Practice Bulletin No. 175: Ultrasound in Pregnancy.

54.Committee Opinion No. 681: Disclosure and Discussion of Adverse Events.

55.Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology.